Searched for
COVAXIN BHARAT BIOTECH
Bharat Biotech credited ICMR, NIV as Covaxin co-inventors after missing them initially: GovernmentResponding to Trinamool Congress member Sougata Roy, who had asked whether the government took any punitive action against the company for ...- No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO suspension"For the millions who have received COVAXIN, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety...
- WHO suspends UN supply of Bharat Biotech's Covaxin citing 'deficiencies'The WHO asked countries that have received the vaccine to take appropriate actions, according to the statement, but did not specify what th...
- Covaxin to be evaluated as COVID-19 vaccine candidate in US: Bharat BiotechCovaxin has already been granted Emergency Use Listing (EUL) in 13 countries as on January 31 according to the WHO. Covaxin was granted EUL...
- Covaxin gets WHO nod for emergency use, move to ease travel for those who took made-in-India vaccineCovaxin was also reviewed by WHO's Strategic Advisory Group of Experts on Immunisation (SAGE), which recommended the use of the vaccine in ...
- Covaxin gets WHO approval for emergency use listingWHO's TAG is an independent advisory group that provides recommendations to the WHO on whether a Covid 19 vaccine can be listed for emergen...
- Bharat Biotech's Covaxin gets WHO okay for emergency useHyderabad-based Bharat Biotech, which has developed Covaxin, submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine'...
- Decision on Bharat Biotech's Covaxin EUL in October, says WHOThe latest 'Status of COVID-19 vaccines within WHO EUL/PQ evaluation process' guidance document dated September 29 on the WHO website said ...
- Covaxin receives GMP certificate from Hungary: Bharat BiotechBharat Biotech intends to submit documentation for emergency use authorisation to several additional countries worldwide, the company said.
- After suspending EUA request, Brazil now shelves import authorisation of CovaxinAccording to a statement issued by the National Health Surveillance Agency of Brazil, Anvisa its Collegiate Board on Tuesday took a decisio...
- Brazil suspends clinical trials of Bharat Biotech's Covaxin“The Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studi...
- All documents for Covaxin emergency use listing submitted to WHO, expect approval at earliest: Bharat BiotechAccording to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during public hea...
- Bharat Biotech ties up with Ocugen to commercialise Covaxin in CanadaUnder the agreement, Ocugen will have the US rights to the vaccine candidate and will be responsible for clinical development, regulatory a...
- Covaxin phase 3 full trial data to be made public in July: Bharat BiotechThe indigenous whole virion inactivated SARS-Cov-2 virus vaccine company has also said that Covaxin will even undergo the phase 4 trials to...
- Ocugen pays $15 mn upfront to Bharat Biotech for Covaxin rights in CanadaThe Indian biotech company and Ocugen Inc have entered into a definitive agreement to co-develop, supply, and commercialise Covaxin for the...
- Covaxin can neutralise double mutant variantPhase 3 clinical trials of Covaxin by Bharat Biotech International Ltd (BBIL) and ICMR have demonstrated 100% efficacy against severe Covid...
- Covaxin shows 100% efficacy against severe Covid-19, works well on variants“The tireless efforts of our scientists at ICMR and BBIL have resulted in a truly effective international vaccine of the highest standards ...
- Bharat Biotech inks pact with Precisa Medicamentos for Covaxin supplies to BrazilThe Brazilian Ambassador to India Andr Aranha Corra do Lago expressed keen interest on behalf of his government towards procuring the vacci...
- Timeline: How India's coronavirus vaccine got approved by drugs expertsCOVAXIN has been developed by Bharat Biotech, a company based in Hyderabad, with backing from the state-run Indian Council of Medical Resea...
- After Haryana's Anil Vij tests positive, Bharat Biotech says COVAXIN efficacious, safe"COVAXIN clinical trials are based on a two-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days after the s...
Load More
